0
No votes yet
Open Access Article
Article

Hematologic Effects

Gail B. Johnson
Kimberly Quiett
CJON 2007, 11(1), 138-150 DOI: 10.1188/07.CJON.138-150

This excerpt, chapter 7 from the book Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice, edited by Susan A. Ezzone, MS, RN, CNP, is part of a series of clinically relevant reprints that appear regularly in the Clinical Journal of Oncology Nursing.

References 

Alcoser, P.W., & Burchett, S. (1999). Bone marrow transplantation: Immune system suppression and reconstitution. <i>American Journal of Nursing</i>, 99, 26-32.

American Society of Clinical Oncology. (1996). Guidelines for use of CSFs as adjuncts to progenitor cell transplants. <i>Journal of Clinical Oncology</i>, 14, 1957-1960.

Anderson, D., DeFor, T., Burns, L., McGlave, P., Miller, J., Wagner, J., et al. (2003). A comparison of related donor peripheral blood and bone marrow transplants: Importance of late-onset chronic graft-versus-host disease and infections. <i>Biology of Blood and Marrow Transplantation</i>, 9(1), 52-59.

Armitage, J.O., & Antman, K.H. (Eds.). (1992). <i>High-dose cancer therapy. Pharmacology, hematopoietins, stem cells</i>. Baltimore: Lippincott Williams and Wilkins.

Baldwin, P.D. (2002). Febrile nonhemolytic transfusion reactions. <i>Clinical Journal of Oncology Nursing</i>, 6, 171-173.

Barnes, R.A. (1998a). Fungal infections. In J. Barrett & J.G. Treleaven (Eds.), <i>The clinical practice of stem cell transplantation, vol.</i>2 (pp. 723-740). St. Louis, MO: Mosby.

Barnes, R.A. (1998b). Other infections. In J. Barrett & J.G. Treleaven (Eds.), <i>The clinical practice of stem cell transplantation, vol.</i>2 (pp. 741-744). St. Louis, MO: Mosby.

Belcher, A.E. (1993). <i>Blood disorders</i>. St. Louis, MO: Mosby.

Beutler, E. (1993). Platelet transfusions: The 20,000/ul trigger. <i>Blood</i>, 81, 1411-1413.

Beyer, J., Schwella, N., Zingsem, J., Strohscheer, I., Schwanter, I., Oettle, H., et al. (1995). Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomized comparison. <i>Journal of Clinical Oncology</i>, 13, 1328-1335.

Bishop, M.R., Tarantolo, S.R., Geller, R.B., Lynch, J.C., Bierman, P.J., Pavletic, Z.S., et al. (2000). A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation. <i>Blood</i>, 96, 80-85.

Bittencourt, H., Rocha, V., Chevret, S., Socie, G., Esperou, H., Devergie, A., et al. (2002). Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. <i>Blood</i>, 99, 2726-2733.

Boeckh, M., & Boivin, G. (1998). Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. <i>Clinical Microbiology Review</i>, 11, 533-554.

BRT Laboratories. (2000). <i>Thrombotic thrombocytopenia purpura</i>. Retrieved November 6, 2003, from <a target="_blank" href='http://www.rhlab.com/Winter2000.htm'>http://www.rhlab.com/Winter2000.htm...

Buchsel, P.C. (1997). Allogeneic bone marrow transplantation. In S.L. Groenwald, M.H. Frogge, M. Goodman, & C.H. Yarbro (Eds.), <i>Cancer nursing: Principles and practice</i> (pp. 459-506). Sudbury, MA: Jones and Bartlett.

Centers for Disease Control and Prevention, Infectious Diseases Society of America, & American Society of Blood and Marrow Transplantation. (2000). Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. <i>Biology of Blood and Marrow Transplantation</i>, 6, 659-702.

Chamberland, M.E. (2002). Emerging infectious agents: Do they pose a risk to the safety of transfused blood and blood products? <i>Clinical Infectious Disease</i>, 34, 797-805.

Champlin, R.E., Schmitz, N., Horowitz, M.M., Chapuis, B., Chopra, R., Cornelissen, J.J., et al. (2000). Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. <i>Blood</i>, 95, 3702-3709.

de Azevedo, A.M., Nucci, M., Maiolino, A., Vigorito, A.C., Simoes, B.P., Aranha, F.J.P., et al. (2002). A randomized multicenter study of G-CSF starting on day +1 versus day +5 after autologous peripheral blood progenitor cell transplantation. <i>Bone Marrow Transplantation</i>, 29, 745-751.

Deeg, H.J. (1990). Delayed complications and long term effects after bone marrow transplantation. <i>Hematology/Oncology Clinics of North America</i>, 4, 641-657.

Dominietto, A., Raiola, A.M., van Lint, M.T., Lamparelli, T., Gualandi, F., Berisso, G., et al. (2001). Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: Graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. <i>British Journal of Haematology</i>, 112, 219-227.

Ellerhorst-Ryan, J. (1997). Infection. In S.L. Groenwald, M.H. Frogge, M. Goodman, & C.H. Yarbro (Eds.), <i>Cancer nursing: Principles and practice</i> (pp. 585-603). Sudbury, MA: Jones and Bartlett.

Ener, R.A., Meglathery, S.B., Cuhaci, B., Topolsky, D., Styler, M.J., Crilley, P., et al. (2001). Use of granulocyte colony-stimulating factor after high-dose chemotherapy and autologous peripheral blood stem cell transplantation: What is the optimal timing? <i>American Journal of Clinical Oncology</i>, 24, 19-25.

Erickson, J.M. (1996). Anemia. <i>Seminars in Oncology Nursing</i>, 12(1), 2-14.

Ezzone, S. (Ed.). (1997). <i>Peripheral blood stem cell transplantation: Recommendations for nursing education and practice</i>. Pittsburgh, PA: Oncology Nursing Society.

Franco, T., & Gould, D.A. (1994). Allogeneic bone marrow transplant. <i>Seminars in Oncology Nursing</i>, 10, 3-11.

Fuller, A.K. (1990). Platelet transfusion therapy for thrombocytopenia. <i>Seminars in Oncology Nursing</i>, 6, 123-128.

George, J.N., & Rizvi, A.H. (2001). Diagnosis and management of thrombocytopenia. In R.W. Coman, J. Hirsh, V.J. Marder, A.W. Clowes, & J.N. George (Eds.), <i>Hemostasis and thrombosis: Basic principles and clinical practice</i> (pp. 1021-1031). Philadelphia: Lippincott Williams and Wilkins.

George, J.N., Vesely, S.K., & Rizvi, A.H. (2001). Thrombotic thrombocytopenia purpura-hemolytic uremic syndrome. In R.W. Coman, J. Hirsh, V.J. Marder, A.W. Clowes, & J.N. George (Eds.), <i>Hemostasis and thrombosis: Basic principles and clinical practice</i> (pp. 1234-1242). Philadelphia: Lippincott Williams and Wilkins.

Gillespie, T.W. (2002). Effects of cancer-related anemia on clinical and quality of life outcomes. <i>Clinical Journal of Oncology Nursing</i>, 6, 206-211.

Glaspy, J.A., Jadeja, J.S., Justice, G., Kessler, J., Richards, D., Schwartzberg, L., et al. (2002). Darbepoetin alfa given every 1-2 weeks alleviates anemia associated with cancer therapy. <i>British Journal of Cancer</i>, 87, 268-276.

Groenwald, S.L., Frogge, M.H., Goodman, M., & Yarbro, C.H. (Eds.). (1997). <i>Cancer nursing: Principles and practice</i> (4th ed.). Sudbury, MA: Jones and Bartlett.

Groopman, J.F., & Itri, L.M. (1999). Chemotherapy-induced anemia in adults: Incidence and treatment. <i>Journal of the National Cancer Institute</i>, 91, 1616-1634.

Guertler, L. (2002). Virus safety of human blood, plasma, and derived products. <i>Thrombosis Research</i>, 107(Suppl. 1), S39.

Herrmann, R.P., Trent, M., Cooney, J., & Cannell, P.K. (1999). Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma. <i>Bone Marrow Transplantation</i>, 24, 1213-1217.

International Bone Marrow Transplant Registry/Autologous Blood and Marrow Transplant Registry. (2003). Report on the state of the art in blood and marrow transplantation. <i>IBMTR/ABMTR Newsletter</i>, 10, 1.

Junghanss, C., & Marr, K.A. (2002). Infectious risks and outcomes after stem cell transplantation: Are nonmyeloablative transplants changing the picture? <i>Current Opinion in Infectious Diseases</i>, 15, 347-353.

Kiss, J.E., Rybka, W.B., Winkelstein, A., deMagalhaes-Silverman, M., Lister, J., Andrea, P.D., et al. (1997). Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. <i>Bone Marrow Transplantation</i>, 19, 303-310.

Klumpp, T.R., Goldberg, S.L., & Mangan, K.F. (1995). Effect of granulocyte colony-stimulating factor on the rate of neutrophil engraftment following peripheral-blood stem-cell transplantation. <i>Journal of Clinical Oncology</i>, 13, 935-961.

Labovich, T.M. (1997). Transfusion therapy: Nursing implications. <i>Clinical Journal of Oncology Nursing</i>, 1, 61-72.

Lee, S.J., Klar, N., Weeks, J.C., & Antin, J.H. (2000). Predicting costs of stem cell transplantation. <i>Journal of Clinical Oncology</i>, 18, 64-71.

Loney, M., & Chernecky, C. (2000). Anemia. <i>Oncology Nursing Forum</i>, 27, 951-964.

Lum, L.G. (1990). Immune recovery after bone marrow transplantation. <i>Hematology/Oncology Clinics of North America</i>, 4, 659-669.

Marr, K.A. (2001). Antifungal prophylaxis in hematopoietic stem cell transplant recipients. <i>Oncology</i>, 15(11, Suppl. 9), 15-19.

Marr, K.A., Carter, R.A., Crippa, F., Wald, A., & Corey, L. (2002). Epidemiology and outcomes of mold infections of hematopoietic stem cell transplant recipients. <i>Clinical Infectious Diseases</i>, 34, 909-917.

Meisenberg, B.R., Ferran, K., Hollenbach, K., Brehm, T., Jollon, J., & Piro, L.D. (1998). Reduced charges and costs associated with outpatient autologous stem cell transplantation. <i>Bone Marrow Transplantation</i>, 21, 927-932.

Moake, J.L., & Byrnes, J.J. (1996). Thrombotic microangiopathies associated with drugs and bone marrow transplantation. <i>Hematology/Oncology Clinics of North America</i>, 10, 485-497.

National Cancer Institute. (1999). <i>Common toxicity criteria</i> (version 2.0). Bethesda, MD: Author.

Nichols, W.G., & Boeckh, M. (2000). Conference report: 2nd International Conference on Transplant Infectious Disease. <i>Transplantation</i>, 1, 3.

Osarogiagbon, R.U., Defor, T.E., Weisdorf, M.A., Erice, A., & Weisdorf, D.J. (2000). CMV antigenemia following bone marrow transplantation: Risk factors and outcomes. <i>Biology of Blood and Marrow Transplantation</i>, 6, 280-288.

Passweg, J.R., Rowlings, P.A., Atkinson, K.A., Barrett, A.J., Gale, R.P., Gratwohl, A., et al. (1998). Red blood cell transfusions for anemia. <i>Seminars in Oncology Nursing</i>, 6, 117-122.

Pavletic, Z.S., Bishop, M.R., Tarantolo, S.R., Martin-Algarra, S., Bierman, P.J., Vose, J.M., et al. (1997). Hematopoietic recovery after allogeneic blood stem cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. <i>Journal of Clinical Oncology</i>, 15, 1608-1616.

Phillips, G.L. (1999). Management of infections. In H.J. Deeg, H.G. Klingemann, G.L. Phillips, & G. Van Zant (Eds.), <i>A guide to blood and marrow transplantation</i> (pp. 143-158). New York: Springer.

Pirker, R., & Smith, R. (2002). Darbepoetin alfa. Potential role in managing anemia in cancer patients. <i>Expert Review of Anticancer Therapy</i>, 2, 377.

Plaza, I.L. (2000, May). A practical approach to blood component transfusion therapy. <i>Transfusion Medicine Update</i>. Pittsburgh, PA: Institute for Transfusion Medicine.

Prentice, G., Grundy, J.E., & Kho, P. (1998). Cytomegalovirus. In J. Barrett & J.G. Treleaven (Eds.), <i>The clinical practice of stem cell transplantation, vol.</i>2 (pp. 697-707). St. Louis, MO: Mosby.

Rieger, P.T., & Haeuber, D. (1995). A new approach to managing chemotherapy-related anemia: Nursing implications of epoetin alfa. <i>Oncology Nursing Forum</i>, 22, 71-81.

Riley, U. (1998). Bacterial infections. In J. Barrett & J.G. Treleaven (Eds.), <i>The clinical practice of stem cell transplantation, vol.</i>2 (pp. 690-696). St. Louis, MO: Mosby.

Rogers, B. (2002). Management of anemia in the ambulatory patient with cancer. <i>Oncology Supportive Care Quarterly</i>, 1(1), 19-26.

Rowe, J.M., Ciobanu, N., Ascensao, J., Stadtmauer, E.A., Weiner, R.S., Schenkein, D.P., et al. (1994). Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. <i>Annals of Internal Medicine</i>, 120, 143-158.

Russell, J.A., Chaudhry, A., Booth, K., Brown, C., Woodman, R.C., Valentine, K., et al. (2000). Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience. <i>Biology of Blood and Marrow Transplantation</i>, 6, 109-114.

Rust, D.M., Wood, L.S., & Battiato, L.A. (1999). Oprelvekin. An alternative treatment for thrombocytopenia. <i>Clinical Journal of Oncology Nursing</i>, 3, 57-62.

Rutherford, C.J., & Frenkel, E.P. (1994). Thrombocytopenia. Issues in diagnosis and therapy. <i>Medical Clinics of North America</i>, 78, 555-575.

Shapiro, T.W., Davison, D.B., & Rust, D.M.A. (1997). <i>Clinical guide to stem cell and bone marrow transplantation</i>. Sudbury, MA: Jones and Bartlett.

Shuey, K.M. (1996). Platelet-associated bleeding disorders. <i>Seminars in Oncology Nursing</i>, 12, 15-27.

Shulman, K.A., Birch, R., Zhen, B., Pania, N., & Weaver, C.H. (1999). Effect of CD34+ cell dose on resource utilization in patients after high-dose chemotherapy with peripheral blood stem cell support. <i>Journal of Clinical Oncology</i>, 17, 1227-1233.

Sniecinski, I.J., & O'Donnell, M.R. (1999). Hemolytic complications of hematopoietic cell transplantation. In E.D. Thomas, K.G. Blume, & S.J. Forman (Eds.), <i>Hematopoietic cell transplantation</i> (2nd ed., pp. 674-682). Melbourne, Australia: Blackwell Science.

Triulzi, D.J. (2000). <i>Leuko reduction. Transfusion medicine update</i>. Retrieved January 13, 2004, from <a target="_blank" href='http://www.itxm.org/TMU200/TMU3_4-2000.htm'>http://www.itxm.org/TMU200/T...

Uderzo, C., Fumagalli, M., DeLorenzo, P., Busca, A., Vassallo, E., Bonanomi, S., et al. (2000). Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. <i>Bone Marrow Transplantation</i>, 26, 1005-1009.

van Burik, J.H., & Weisdorf, D.J. (1999). Infections in recipients of blood and marrow transplantation. <i>Hematology/Oncology Clinics of North America</i>, 13, 1065-1089.

Vreilink, H., & Reesink, H.W. (1998). Transfusion transmissible infections. <i>Current Opinion in Hematology</i>, 6, 396-405.

Wagner, N.D., & Quinones, V.W. (1999). Allogeneic peripheral blood stem cell transplantation: Clinical overview and nursing implications. <i>Oncology Nursing Forum</i>, 25, 1049-1055.

Walker, F., & Burcat, S. (1997). Hematologic effects of transplantation. In M.B. Whedon & D. Wujcik (Eds.), <i>Blood and marrow stem cell transplantation: Principles, practice, and nursing insights</i> (pp. 205-219). Sudbury, MA: Jones and Bartlett.

Walker, F., Roethke, S.K., & Martin, G. (1994). An overview of the rationale, process and nursing implications of peripheral blood stem cell transplantation. <i>Cancer Nursing</i>, 17, 141-148.

Westmoreland, D. (1998). Other viral infections. In J. Barrett & J.G. Treleaven (Eds.), <i>The clinical practice of stem cell transplantation, vol.</i>2 (pp. 709-721). St. Louis, MO: Mosby.

Whedon, M.B., & Wujcik, D. (Eds.). (1997). <i>Blood and marrow stem cell transplantation: Principles, practice, and nursing insights</i> (2nd ed.). Sudbury, MA: Jones and Bartlett.